SecurityHIL / Hill International, Inc. (431466101)
President and CEORichter David L
IndustryEngineering Services
Institutional Owners63
Institutional Shares34,632,922 - 65.39%
Common Shares Outstanding52,960,817 shares (as of 2017-03-31)
Institutional Value$ 231,947,000 USD

Institutional Stock Ownership and Shareholders()

HIL / Hill International, Inc. Institutional Ownership

Hill International, Inc. (NYSE:HIL) has 63 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 34,632,922 shares. Largest shareholders include Engine Capital Management, LLC, Bulldog Investors, LLC, Ancora Advisors, LLC, BlackRock Inc., Petrus Trust Company, LTA, Dimensional Fund Advisors Lp, Thomson Horstmann & Bryant Inc, Vanguard Group Inc, 22nw, Lp, and Wells Fargo & Company/mn.
Hill International, Inc. (NYSE:HIL) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/hil"><img src="https://images.fintel.io/us-hil-so.png" alt="HIL / Hill International, Inc. Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2017-02-10 13F-HR BlackRock Investment Management, LLC 145,941 142,221 -2.55 673 619 -8.02
2018-05-02 13F-HR RHUMBLINE ADVISERS 30,805 29,430 -4.46 168 168 0.00
2018-05-14 13F-HR Renaissance Technologies LLC 494,500 407,200 -17.65 2,695 2,321 -13.88
2018-05-15 13F-HR TWO SIGMA SECURITIES, LLC 12,521 0 -100.00 68 0 -100.00
2018-05-15 13F-HR TWO SIGMA INVESTMENTS LLC 40,070 0 -100.00 218 0 -100.00
2018-05-01 13F-HR Lapides Asset Management, LLC 268,800 268,800 0.00 1,465 1,532 4.57
2018-05-15 13F-HR MENTA CAPITAL LLC 32,886 20,746 -36.92 179 118 -34.08
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 4,189 7,202 71.93 23 41 78.26
2018-05-10 13F-HR THOMSON HORSTMANN & BRYANT INC 1,989,508 1,910,197 -3.99 10,842 10,888 0.42
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 275,563 277,655 0.76 1,501 1,582 5.40
2018-05-14 13F-HR PARAMETRIC PORTFOLIO ASSOCIATES LLC 60,250 0 -100.00 328 0 -100.00
2018-05-11 13F-HR DIMENSIONAL FUND ADVISORS LP 2,138,245 2,082,259 -2.62 11,653 11,869 1.85
2018-05-07 13F-HR AMERICAN INTERNATIONAL GROUP INC 22,985 21,812 -5.10 125 124 -0.80
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. 600 0 -100.00 3 0 -100.00
2018-05-11 13F-HR CITADEL ADVISORS LLC 37,432 213
2018-04-30 13F-HR TCI Wealth Advisors, Inc. 437 437 0.00 2 2 0.00
2018-04-20 13F-HR STRS OHIO 120,900 114,900 -4.96 658 654 -0.61
2018-05-11 13F-HR BNP PARIBAS ARBITRAGE, SA 6,465 6,693 3.53 35,234 38,150 8.28
2018-05-15 13F-HR 22NW, LP 1,613,253 1,764,158 9.35 8,792 10,056 14.38
2018-05-15 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 30,247 29,201 -3.46 165 167 1.21
2018-05-14 13F-HR TEACHERS ADVISORS INC 65,570 65,570 0.00 357 374 4.76
2018-05-10 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 244,045 200,559 -17.82 1,330 1,143 -14.06
2018-05-15 13F-HR STATE STREET CORP 524,782 541,967 3.27 2,859 3,089 8.04
2017-02-10 13F-HR BlackRock Fund Advisors 906,612 1,059,576 16.87 4,179 4,609 10.29
2018-05-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 90,090 81,240 -9.82 491 463 -5.70
2018-05-02 13F-HR NJ State Employees Deferred Compensation Plan 100,000 110,000 10.00 545 627 15.05
2018-05-14 13F-HR Bulldog Investors, LLC 3,373,163 3,570,458 5.85 18,384 20,352 10.70
2018-05-15 13F-HR Bank of New York Mellon Corp 115,121 121,323 5.39 627 692 10.37
2018-05-04 13F-HR STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 15,851 15,851 0.00 86 90 4.65
2018-05-14 13F-HR/A CITADEL ADVISORS LLC 0 37,432 0 213
2018-05-15 13F-HR BRIDGEWAY CAPITAL MANAGEMENT INC 201,551 201,551 0.00 1,098 1,149 4.64
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 1,051,514 1,051,514 0.00 4,847 4,574 -5.63
2018-05-15 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 54,159 52,704 -2.69 295 300 1.69
2018-05-11 13F-HR CITIGROUP INC 290 2,867 888.62 2 16 700.00
2018-05-16 13F-HR Foundry Partners, LLC 579,280 586,705 1.28 3,157 3,344 5.92
2018-05-15 13F-HR PERRITT CAPITAL MANAGEMENT INC 1,055,200 994,140 -5.79 5,751 5,617 -2.33
2018-05-10 13F-HR JP Morgan Chase & Co 14,476 35,139 142.74 79 200 153.16
2018-05-08 13F-HR KOKINO LLC 148,120 158,996 7.34 807 906 12.27
2018-05-11 13F-HR Delpha Capital Management, Llc 205 0 -100.00 1 0 -100.00
2018-04-13 13F-HR BANK OF MONTREAL /CAN/ 3,297 3,297 0.00 18 19 5.56
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 5,422 5,400 -0.41 29 31 6.90
2018-05-14 13F-HR Axa 0 17,700 0 101
2018-05-15 13F-HR Voya Investment Management LLC 18,616 18,616 0.00 101 106 4.95
2018-05-17 13F-HR Legal & General Group Plc 6,480 6,480 0.00 35 37 5.71
2018-04-26 13F-HR RUTABAGA CAPITAL MANAGEMENT LLC/MA 908,400 895,500 -1.42 4,951 5,104 3.09
2018-05-07 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 62,000 62,000 0.00 338 354 4.73
2018-05-14 13F-HR Stone Ridge Asset Management LLC 65,094 65,094 0.00 355 371 4.51
2018-05-09 13F-HR NORTHERN TRUST CORP 412,785 424,926 2.94 2,249 2,422 7.69
2018-05-15 13F-HR Ameritas Investment Partners, Inc. 2,159 2,159 0.00 12 12 0.00
2018-05-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 24,900 24,900 0.00 136 142 4.41
2018-05-15 13F-HR DEUTSCHE BANK AG\ 151,488 111,603 -26.33 824 635 -22.94
2018-05-09 13F-HR FEDERATED INVESTORS INC /PA/ 825 0 -100.00 4 0 -100.00
2018-05-15 13F-HR Engine Capital Management, LLC 4,834,483 5,179,891 7.14 26,348 29,525 12.06
2018-05-04 13F-HR PRUDENTIAL FINANCIAL INC 19,770 0 -100.00 108 0 -100.00
2018-05-15 13F-HR UBS Group AG 3,581 927 -74.11 19 5 -73.68
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC 23,668 12,194 -48.48 129 70 -45.74
2018-04-26 13F-HR SIMPLEX TRADING, LLC 246 0 -100.00 1 0 -100.00
2018-05-15 13F-HR VANGUARD GROUP INC 1,621,641 1,874,853 15.61 8,838 10,687 20.92
2018-05-15 13F-HR HAWK RIDGE CAPITAL MANAGEMENT LP 612,500 612,500 0.00 3,338 3,491 4.58
2018-05-15 13F-HR Petrus Trust Company, LTA 2,483,726 2,263,527 -8.87 13,536 12,902 -4.68
2018-05-09 13F-HR BlackRock Inc. 2,306,233 2,301,877 -0.19 12,569 13,120 4.38
2018-05-15 13F-HR Ancora Advisors, LLC 1,838,997 2,453,747 33.43 10,022 13,987 39.56
2018-05-15 13F-HR Invesco Ltd. 0 76,743 0 437
2017-08-14 13F-HR Tappan Street Partners LLC 558,470 900,000 61.15 2,318 4,680 101.90
2018-05-15 13F-HR TWO SIGMA ADVISERS, LP 15,300 19,600 28.10 83 112 34.94
2018-05-15 13F-HR JANE STREET GROUP, LLC 12,938 0 -100.00 71 0 -100.00
2018-05-14 13F-HR MORGAN STANLEY 69,832 75,003 7.40 381 428 12.34
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 14,335 0 -100.00 78 0 -100.00
2018-05-15 13F-HR CREDIT SUISSE AG/ 0 12,444 0 71
2017-02-10 13F-HR BlackRock Advisors LLC 18,532 19,931 7.55 85 87 2.35
2018-04-18 13F-HR Creative Planning 108,500 108,500 0.00 591 618 4.57
2018-05-15 13F-HR Parallax Volatility Advisers, L.P. 5,460 0 -100.00 30 0 -100.00
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 9,591 0 -100.00 52 0 -100.00
2018-05-15 13F-HR BARCLAYS PLC 5,812 7,078 21.78 31 40 29.03
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 1,279,552 1,067,329 -16.59 6,973 6,084 -12.75
2018-05-15 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC 1,829 1,168 -36.14 10 7 -30.00

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Related News Stories

BRIEF-Hill International Announces Restatement Filing

2018-05-08 reuters
* HILL INTERNATIONAL INC - PLANS TO FILE ITS QUARTERLY REPORTS ON FORM 10-Q FOR QUARTERS ENDED JUNE 30 AND SEPTEMBER 30, 2017, BY END OF Q2 OF 2018 (1-1)

BRIEF-Hill International Expands Presence In India With Multiple Rail / Metro Project Selections

2018-05-03 reuters
* HILL INTERNATIONAL INC - AWARDS HAVE A TOTAL PROJECT VALUE ESTIMATED AT NEARLY $4 BILLION (1-0)

BRIEF-Hill International Reiterates Previously Issued 2018 Guidance

2018-03-30 reuters
* HILL INTERNATIONAL - REITERATES PREVIOUSLY ISSUED 2018 GUIDANCE, EXPECTS CONSULTING FEE REVENUE BETWEEN $400 MILLION AND $415 MILLION FOR 2018 - SEC FILING Source text: (bit.ly/2GKDEAd) Further company coverage: (1-0)

CUSIP: 431466101